Artificial intelligence and robotics are playing an increasingly important role in the healthcare and life sciences industries. Multiply Labs, a biotechnology company focused on precision medicine manufacturing, is leveraging NVIDIA’s advanced robotics and simulation platforms to automate and scale the production of cell therapies. By integrating technologies such as NVIDIA Omniverse and NVIDIA Isaac Sim, the company aims to improve efficiency, reduce costs, and expand access to advanced medical treatments.

Transforming Cell Therapy Manufacturing

Cell therapy is a cutting-edge medical treatment that involves modifying patient or donor cells to treat diseases such as cancer, genetic disorders, autoimmune diseases, and neurological conditions. However, producing these therapies is highly complex, expensive, and difficult to scale using traditional manual laboratory processes.

Multiply Labs addresses these challenges by developing robotic systems capable of performing precise laboratory tasks. The company focuses on automating complex manufacturing workflows to increase production capacity while maintaining strict quality and safety standards.

Using Digital Twins for Advanced Simulation

A key component of Multiply Labs’ approach is the use of digital twin technology powered by NVIDIA Omniverse. Digital twins are virtual replicas of physical environments that allow researchers to simulate laboratory operations and robotic workflows in highly realistic virtual settings.

By creating digital twins of laboratory environments, Multiply Labs can run thousands of simulations to test robotic processes, detect potential issues, and optimize workflows before deploying robots in real-world facilities. This simulation-first approach helps reduce development risks and significantly improves system reliability.

Training Robots with NVIDIA Isaac Sim

Multiply Labs also utilizes NVIDIA Isaac Sim, a robotics simulation framework that allows robots to learn specialized laboratory tasks. Using this platform, robots are trained to perform delicate procedures such as cell handling and material processing through realistic virtual simulations.

The company applies techniques such as imitation learning, where robots learn tasks by analyzing demonstrations performed by expert scientists. This method helps capture complex human skills and translate them into robotic automation, ensuring accuracy and consistency in laboratory operations.

Introducing Humanoid Robotics for Laboratory Support

Beyond robotic arms and automation clusters, Multiply Labs is also exploring humanoid robots based on NVIDIA’s Isaac GR00T foundation model. These humanoid robots are designed to support laboratory workflows while maintaining strict hygiene standards required in cleanroom environments.

By integrating humanoid robotics into laboratory operations, Multiply Labs aims to improve efficiency, minimize contamination risks, and enhance the overall scalability of biomanufacturing processes.

Improving Efficiency and Reducing Costs

Robotic automation in cell therapy manufacturing offers significant operational benefits. Studies and industry reports indicate that robotics-driven manufacturing can dramatically increase production throughput and reduce treatment costs. In some cases, robotic systems have shown the potential to reduce production costs by up to 70% and significantly increase manufacturing capacity within limited laboratory space.

Additionally, robotic systems help ensure consistency and precision, reducing the variability and contamination risks often associated with manual laboratory processes.

The Future of AI-Driven Biomanufacturing

Multiply Labs’ collaboration with NVIDIA demonstrates how AI, robotics, and simulation technologies are transforming life sciences and healthcare industries. By combining digital twins, robotic automation, and AI-powered learning systems, researchers can accelerate drug manufacturing and improve access to advanced therapies.

As these technologies continue to evolve, automation and AI-driven robotics are expected to play a critical role in scaling personalized medicine and enabling more efficient healthcare solutions worldwide.

Source: https://blogs.nvidia.com/blog/multiply-labs-isaac-omniverse/